Compugen (CGEN) Stock Forecast, Price Target & Predictions


OverviewOwnershipChartTranscripts

CGEN Stock Forecast


Compugen (CGEN) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $4.00, with a high of $4.00 and a low of $4.00. This represents a 140.96% increase from the last price of $1.66.

High: $4 Avg: $4 Low: $4 Last Closed Price: $1.66

CGEN Stock Rating


Compugen stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 0 12 Strong Sell Sell Hold Buy Strong Buy

CGEN Price Target Upside V Benchmarks


TypeNameUpside
StockCompugen140.96%
SectorHealthcare Stocks 23.68%
IndustryBiotech Stocks 64.77%

Price Target Trends


1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.66$1.66$1.66
Upside/Downside---
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-4---4
May, 25-4---4
Apr, 25-4---4
Mar, 25-4---4
Feb, 25-4---4
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 21, 2024Asthika GoonewardeneTruist Financial$4.00$1.74129.89%140.96%
May 20, 2024Stephen WilleyStifel Nicolaus$4.00$1.74129.89%140.96%
May 20, 2024Asthika GoonewardeneTruist Financial$5.00$1.74187.36%201.20%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Feb 08, 2023JefferiesUnderperformdowngrade
Nov 15, 2022OppenheimerOutperformOutperformhold
Aug 08, 2022JMP SecuritiesMarket OutperformMarket Outperformhold
Feb 25, 2022OppenheimerOutperformOutperformhold
Feb 25, 2022SVB LeerinkOutperformOutperformhold

Financial Forecast


EPS Forecast

Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.34$-0.39$-0.21-----
Avg Forecast$-0.37$-0.44$-0.19$-0.07$-0.18$-0.24$-0.29$-0.31
High Forecast$-0.28$-0.33$0.24$0.54$0.21$-0.04$-0.12$-0.13
Low Forecast$-0.46$-0.54$-0.43$-0.40$-0.41$-0.46$-0.61$-0.66
Surprise %-8.11%-11.36%10.53%-----

Revenue Forecast

$0 $17M $34M $51M $68M $85M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.00M$6.00M$33.46M-----
Avg Forecast$2.00M$6.76M$22.67M$37.60M$24.58M$36.80M$34.60M$44.88M
High Forecast$2.40M$7.99M$40.30M$63.02M$45.38M$37.86M$63.88M$82.86M
Low Forecast$1.60M$5.46M$5.04M$24.77M$13.72M$35.75M$19.32M$25.06M
Surprise %--11.21%47.61%-----

Net Income Forecast

$-100M $-70M $-40M $-10M $20M $50M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-27.26M$-32.87M$-18.75M-----
Avg Forecast$-30.95M$-39.92M$-18.75M$1.60M$-10.92M$-10.87M$-17.36M$-27.39M
High Forecast$-24.76M$-31.94M$21.18M$47.03M$18.66M$-3.63M$-10.92M$-11.66M
Low Forecast$-37.14M$-47.90M$-38.12M$-34.76M$-35.98M$-39.98M$-53.83M$-57.51M
Surprise %-11.91%-17.65%------

CGEN Forecast FAQ


Is Compugen stock a buy?

Compugen stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Compugen is a favorable investment for most analysts.

What is Compugen's price target?

Compugen's price target, set by 12 Wall Street analysts, averages $4 over the next 12 months. The price target range spans from $4 at the low end to $4 at the high end, suggesting a potential 140.96% change from the previous closing price of $1.66.

How does Compugen stock forecast compare to its benchmarks?

Compugen's stock forecast shows a 140.96% upside, outperforming the average forecast for the healthcare stocks sector (23.68%) and outperforming the biotech stocks industry (64.77%).

What is the breakdown of analyst ratings for Compugen over the past three months?

  • June 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Compugen’s EPS forecast?

Compugen's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.07, marking a -66.67% decrease from the reported $-0.21 in 2023. Estimates for the following years are $-0.18 in 2025, $-0.24 in 2026, $-0.29 in 2027, and $-0.31 in 2028.

What is Compugen’s revenue forecast?

Compugen's average annual revenue forecast for its fiscal year ending in December 2024 is $37.6M, reflecting a 12.37% increase from the reported $33.46M in 2023. The forecast for 2025 is $24.58M, followed by $36.8M for 2026, $34.6M for 2027, and $44.88M for 2028.

What is Compugen’s net income forecast?

Compugen's net income forecast for the fiscal year ending in December 2024 stands at $1.6M, representing a -108.53% decrease from the reported $-18.754M in 2023. Projections indicate $-10.925M in 2025, $-10.867M in 2026, $-17.361M in 2027, and $-27.385M in 2028.